← Find more feeds

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 179 followers

Latest posts

Last updated 3 days ago

Roche’s virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting

3 days ago

Read full

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

9 days ago

Read full

Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare

10 days ago

Read full

Invitation to Roche’s Full Year Results 2021 Presentation

16 days ago

Read full

Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States

27 days ago

Read full

Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma

about 1 month ago

Read full

Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

about 1 month ago

Read full

Interim data from phase III HAVEN 6 study demonstrate favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A

about 1 month ago

Read full

Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab

about 1 month ago

Read full

Phase II study of Roche’s giredestrant meets primary endpoint in the most frequently diagnosed type of breast cancer

about 1 month ago

Read full

New data from the phase II CITYSCAPE trial show encouraging results with Roche’s novel anti-TIGIT tiragolumab plus Tecentriq

about 1 month ago

Read full

Reminder: Invitation to Roche’s virtual event on key hematology data presented at ASH 2021

about 1 month ago

Read full

Or log in

Everything you care about in one place

Investor Update

Latest posts

Roche’s virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare

Invitation to Roche’s Full Year Results 2021 Presentation

Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States

Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma

Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Interim data from phase III HAVEN 6 study demonstrate favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A

Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab

Phase II study of Roche’s giredestrant meets primary endpoint in the most frequently diagnosed type of breast cancer

New data from the phase II CITYSCAPE trial show encouraging results with Roche’s novel anti-TIGIT tiragolumab plus Tecentriq

Reminder: Invitation to Roche’s virtual event on key hematology data presented at ASH 2021

Try Feeder for free